Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study

BACKGROUND: Cushing’s syndrome (CS) is associated with numerous comorbidities, including diabetes mellitus (DM). Levoketoconazole, an orally administered ketoconazole stereoisomer, is in clinical trials for the treatment of CS. METHODS: SONICS, a prospective, open-label, phase 3 study in adults with...

Descripción completa

Detalles Bibliográficos
Autores principales: Pivonello, Rosario, Elenkova, Atanaska, Fleseriu, Maria, Feelders, Richard A., Witek, Przemyslaw, Greenman, Yona, Geer, Eliza B., Perotti, Paola, Saiegh, Leonard, Cohen, Fredric, Arnaldi, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059833/
https://www.ncbi.nlm.nih.gov/pubmed/33897615
http://dx.doi.org/10.3389/fendo.2021.595894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059833/
https://www.ncbi.nlm.nih.gov/pubmed/33897615
http://dx.doi.org/10.3389/fendo.2021.595894

Ejemplares similares